Loading organizations...
Loading organizations...
Developing orally-delivered antibody therapeutics for various diseases.
Avaxia Biologics has raised $15.5M across 2 funding rounds.
Avaxia Biologics has raised $15.5M in total across 2 funding rounds.
Avaxia Biologics has raised $15.5M in total across 2 funding rounds.
Avaxia Biologics's investors include Robert Manning, Nada Jain, AbbVie Ventures, Ariel Southeast Angel Partners, Beacon Angels, Beta Fund, Boston Harbor Angels, Granite State Angels, Keiretsu Forum, Launchpad Venture Group, Maine Angels, Mass Medical Angels.
Avaxia Biologics has raised $15.5M across 2 funding rounds. Most recently, it raised $11.4M Series B in June 2013.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 7, 2013 | $11.4M Series B | Robert Manning, Nada Jain | AbbVie Ventures, Ariel Southeast Angel Partners, Beacon Angels, Beta Fund, Boston Harbor Angels, Granite State Angels, Keiretsu Forum, Launchpad Venture Group, Maine Angels, Mass Medical Angels, North Country Angels, Tech Coast Angels |
| Feb 14, 2012 | $4.1M Series A | Robert Manning | Beacon Angels, Boston Harbor Angels, Henry Kay, Mass Medical Angels, North Country Angels |